{{Rsnum
|rsid=6869645
|Gene=SLC6A3
|Chromosome=5
|position=1404433
|Orientation=plus
|GMAF=0.06933
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC6A3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 89.4 | 9.7 | 0.9
| HCB | 93.4 | 6.6 | 0.0
| JPT | 97.3 | 2.7 | 0.0
| YRI | 59.2 | 34.7 | 6.1
| ASW | 64.9 | 33.3 | 1.8
| CHB | 93.4 | 6.6 | 0.0
| CHD | 96.3 | 3.7 | 0.0
| GIH | 84.2 | 15.8 | 0.0
| LWK | 78.2 | 20.9 | 0.9
| MEX | 96.6 | 3.4 | 0.0
| MKK | 84.0 | 16.0 | 0.0
| TSI | 95.1 | 4.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20091113
|Title=Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers
}}

{{PMID Auto
|PMID=19673036
|Title=Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}